Tavistock Investments Plc
("Tavistock" or the "Company")
Director appointment
26 January 2023
Tavistock is pleased to announce the appointment of Johanna Rager as a director of the Company with immediate effect. Johanna joined Tavistock in 2019 and is the Group's Finance and Operations Director.
Prior to joining Tavistock, Johanna held senior management positions at Thermo Fisher Scientific Inc. and Parexel International Ltd for over 20 years.
The following disclosures are made in accordance with the AIM Rules for Companies:
Johanna Martina Gabriela Rager-Badesha (formerly Johanna Martina Gabriela Rager), aged 53, is or has been a director or partner of the following companies and partnerships in the past five years:
| Current directorships/partnerships:
| Directorships and partnerships held within the last five years: |
| Tavistock Chater Allan LLP | |
| Cornerstone Asset Holdings Limited | |
| Duchy Independent Financial Advisers Limited | |
| Tavistock Asset Management Limited | |
| Tavistock Estate Planning Services Limited | |
| Tavistock Group Holdings Limited | |
| Tavistock Partners (UK) Limited | |
| Tavistock Partners Limited | |
| Tavistock Services Limited | |
| The Tavistock Partnership Limited | |
| Tavistock Select LLP | |
Johanna Martina Gabriela Rager-Badesha beneficially holds 2,276,000 ordinary shares in the Company.
Save for the information set out above, there are no further disclosures to be made in accordance with Rule 17, Schedule 2(g) of the AIM Rules for Companies in respect of the appointment of Johanna.
For further information:
| Tavistock Investments Plc Oliver Cooke Brian Raven
| Tel: 01753 867000 | |
| Allenby Capital Limited (Nominated adviser and broker) Corporate Finance: Nick Naylor, Nick Athanas, Dan Dearden-Williams Sales and Corporate Broking: Tony Quirke
| Tel: 020 3328 5656 | |
| Powerscourt Gilly Lock Roxane Girard | Tel: 07711 380 007 020 7250 1446 | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
